Another approach is to incorporate additional transgenes so that CAR‐T cells can secrete PD‐1 blocking scFv or anti‐PD‐L1 antibodies at the tumor site simultaneously, enabling the full antitumor function of these tumor‐infiltrating super CAR‐T cells and other intratumoral T cells. This evidence concerns the gene CD274 and neoplasm.